(Q40344129)

19 September 2017

title

Improvement in long-term ECMO by detailed monitoring of anticoagulation: a case report (English)

1 reference

extracorporeal membrane oxygenation

19 September 2017

main subject

1 reference

1 reference

Alicia Sievert

1

1 reference

19 September 2017

Walter Uber

series ordinal

2

1 reference

19 September 2017

Stacey Laws

series ordinal

3

1 reference

19 September 2017

Joel Cochran

series ordinal

4

1 reference

19 September 2017

publication date

5 November 2010

1 reference

19 September 2017

1 reference

19 September 2017

volume

26

1 reference

19 September 2017

issue

1

1 reference

19 September 2017

page(s)

59-64

1 reference

Extracorporeal Life Support Registry Report 2008: neonatal and pediatric cardiac cases

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0267659110385513

Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659110385513

Intracardiac thrombus: a risk of incomplete anticoagulation for cardiac operations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659110385513

The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659110385513

Use of a fixed activated partial thromboplastin time ratio to establish a therapeutic range for unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659110385513

A review of the clinical indications for the plasma heparin assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659110385513

Three different chromogenic methods do not give equivalent anti-Xa levels for patients on therapeutic low molecular weight heparin (dalteparin) or unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659110385513

Monitoring Unfractionated Heparin (UFH) therapy: which Anti-Factor Xa assay is appropriate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659110385513

Thrombelastography/thromboelastometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659110385513

Acute phase reaction and acute phase proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659110385513

Acute-phase proteins and other systemic responses to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659110385513

21 January 2018

Identifiers

DOI

10.1177/0267659110385513

1 reference

19 September 2017

1 reference